Trade

with

Flamel Technologies
(NASDAQ: FLML)
AdChoices
13.00
+0.33
+2.60%
After Hours :
13.01
+0.01
+0.04%

Open

12.80

Previous Close

12.67

Volume (Avg)

160.73k (203.18k)

Day's Range

12.71-13.21

52Wk Range

5.30-15.96

Market Cap.

470.31M

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

38.58M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 22.44M

    • Net Income

    • -42.92M

    • Market Cap.

    • 470.31M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -168.70

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.69

    • Forward P/E

    • 13.00

    • Price/Sales

    • 13.19

    • Price/Book Value

    • 8.67

    • Price/Cash flow

    • -24.81

      • EBITDA

      • -46.43M

      • Return on Capital %

      • -33.41

      • Return on Equity %

      • -204.83

      • Return on Assets %

      • -33.41

      • Book Value/Share

      • 1.50

      • Shares Outstanding

      • 38.58M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 20.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.78

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 45.90

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -10.29

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 80.50

            • 82.75

            • Pre-Tax Margin

            • -198.07

            • 39.38

            • Net Profit Margin

            • -168.70

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 79.20

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -69.70

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -56.40

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.20

              • 0.76

              • Current Ratio

              • 2.78

              • 2.92

              • Quick Ratio

              • 2.56

              • 2.35

              • Interest Coverage

              • -14.05

              • 38.02

              • Leverage Ratio

              • 3.02

              • 2.21

              • Book Value/Share

              • 1.50

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.62

                • 196.08

                • P/E Ratio 5-Year High

                • -9.60

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.71

                • 124.82

                • Price/Sales Ratio

                • 12.85

                • 9.12

                • Price/Book Value

                • 8.45

                • 8.26

                • Price/Cash Flow Ratio

                • -24.81

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -204.83

                        (-98.60)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -33.41

                        (-15.10)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -41.47

                        (-25.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 1.53

                      • 1.48

                      • Asset Turnover

                      • 0.20

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -50.03M
                      Operating Margin
                      -222.94
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -24.81
                      Ownership

                      Institutional Ownership

                      62.52%

                      Top 10 Institutions

                      45.76%

                      Mutual Fund Ownership

                      16.60%

                      Float

                      -

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • JPM Global Healthcare

                      •  

                        1,275,916

                      • 0.00

                      • 3.31

                      • RENN Universal Growth

                      •  

                        799,978

                      • -0.01

                      • 2.09

                      • Prudential Jennison Health Sciences

                      •  

                        704,554

                      • 0.00

                      • 1.83

                      • Deutsche Global Small Cap Fund

                      •  

                        487,632

                      • 0.00

                      • 1.26

                      • Clough Global Opportunities

                      •  

                        370,472

                      • 38.77

                      • 0.96

                      • Dreyfus Select Managers Small Cap Val Fd

                      •  

                        213,749

                      • -26.52

                      • 0.55

                      • Pru Ret Small Cap Value/Kennedy SP

                      •  

                        212,936

                      • 38.01

                      • 0.55

                      • Fidelity® Small Cap Growth Fund

                      •  

                        212,002

                      • -47.00

                      • 0.55

                      • RENN Global Entrepreneurs Fund

                      •  

                        200,000

                      • 0.00

                      • 0.52

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Broadfin Capital, LLC

                      •  

                        5,267,911

                      • 0.00%

                      • 13.65

                      • Deerfield Management Co

                      •  

                        5,258,475

                      • 0.00%

                      • 13.63

                      • J P Morgan Asset Management (UK) Ltd

                      •  

                        1,331,816

                      • -11.66%

                      • 3.45

                      • Renn Capital Group Inc

                      •  

                        999,978

                      • -0.01%

                      • 2.61

                      • Jennison Associates LLC

                      •  

                        819,787

                      • -45.35%

                      • 2.12

                      • Perceptive Advisors LLC

                      •  

                        800,000

                      • 0.00%

                      • 2.07

                      • Millennium Management LLC

                      •  

                        787,835

                      • -37.56%

                      • 2.04

                      • Rock Springs Capital Management LP

                      •  

                        775,000

                      • +3.33%

                      • 2.01

                      • Kennedy Capital Management Inc

                      •  

                        724,610

                      • +61.93%

                      • 1.88

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Growth

                      Flamel Technologies was incorporated as a Societe Anonyme or SA, a form of corporation under the laws of the Republic of France in August 1990 as Flamel Technologies S.A. The Company is a specialty pharmaceutical company with a histo...morery in drug delivery, working on the development of safer and more efficacious formulations. The acquisition of Éclat on March 13, 2012 has created a more vertically integrated company, benefiting from greater development and commercial expertise and more near-term and mid-term potential value creating catalysts. Since its acquisition of Eclat, Flamel is now engaged in not only on the development and licensing of versatile, proprietary drug delivery platforms but also on the development of novel, high-value products based on those delivery platforms. Bloxiverz, the Compan...morey first NDA approval from the portfolio of Eclat products acquired in March 2012. Bloxiverz’s NDA was filed in August 2012 and approved by the FDA on May 2013. The launch of Bloxiverz commenced in July 2013. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Bloxiverz is the first and only FDA-approved version of neostigmine methylsulfate, even though other versions of neostigmine have been on the market as unapproved, grandfathered products under the Food, Drug and Cosmetic Act of 1938. Coreg CR, the lead product using its Micropump drug delivery platform. Coreg CR is an extended-release formulation once-a-day of Coreg a non-selective antagonist of Beta 1, Beta 2 adrenergic receptors and a selective antagonist of Alpha 1 adrenergic receptors. The Company faces competition from Actavis, Alkermes, BioAlliance Pharma, Depomed, Ethypharm, Octoplus, Veloxis Pharmaceuticals, Nektar Therapeutics. The Company owns and develops drug delivery platforms that are able to tackle key challenges in the formulation, in various dosage forms of a broad range of drugs novel, already-marketed, or off-patent that includes Micropump. During the 2013 the Company has 395 patents in total. The design, testing, manufacturing and marketing of certain new or substantially modified drugs, biological products or medical devices must be approved, cleared or certified by regulatory agencies, regulatory authorities and Notified Bodies under applicable laws and regulations, the requirements of which may vary from country to country.lessless

                      Key People

                      Michael S. Anderson

                      CEO/Director

                      Stephen H. Willard

                      Chairman of the Board/Director

                      Sian Crouzet

                      CFO

                      Gregg Stetsko,PhD

                      Vice President, Divisional

                      Craig R. Stapleton

                      Director

                      • Flamel Technologies

                      • Parc Club du Moulin a Vent

                      • Venissieux, 69693

                      • FRA.Map

                      • Phone: +33 472783434

                      • Fax: +33 472783434

                      • flamel.com

                      Incorporated

                      1990

                      Employees

                      251

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: